Latest News about CCC
Recent news which mentions CCC
California's Hemp Ban 'Likely Won't Be The Last': Will It Push Consumers Back To Licensed Operators?
October 03, 2024
Tickers
CCC
From Benzinga
Adult-Use Markets 'Don't Meet Needs Of All Patients': The Overlooked Role Of Medical Marijuana
October 03, 2024
Tickers
CCC
From Benzinga
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
October 02, 2024
From Benzinga
Congressional Bill Is Game-Changer For CBD Regulation, It's 'Long Overdue,' Says Hemp Coalition
October 02, 2024
From Benzinga
From Benzinga
California's New Hemp Rules Could Reshape Cannabis: 'A Different Set Of Rules In Every State'
October 01, 2024
From Benzinga
'Companies With Distinctive Brands Are Gaining Attention': What's Driving Cannabis Investment Today?
October 01, 2024
Tickers
CCC
From Benzinga
Billion-Dollar Cannabis Giant Tilray To Report Earnings, Here's What Investors Can Expect
October 01, 2024
From Benzinga
EXCLUSIVE: This Cannabis-Focused Tech Platform Uses AI-Driven Tools For Smarter Cannabis Retail Management, Here's What Its New Features Offers
October 01, 2024
From Benzinga
How Will California's Hemp Restrictions Change The Cannabis Market: 'There Is A Risk Of This Activity Flooding The US' Says Expert
October 01, 2024
From Benzinga
Ukraine Approves Medical Marijuana For Certain Health Conditions, PTSD Left Out For Now
September 30, 2024
From Benzinga
Medical Marijuana's Role In Cannabis Reform: Why It Can't Be Ignored
September 30, 2024
Tickers
CCC
From Benzinga
GOP Senator Leads Bipartisan Effort To Seal Low-Level Marijuana Possession Records, Providing 'Second Chance'
September 30, 2024
From Benzinga
'No Companies Will Invest': How California's Hemp Rules Could Hurt Cannabis Businesses
September 30, 2024
From Benzinga
'Get Ready For A Nationwide Game Of Whack-A-Mole': What California's Hemp Ban Means For The Industry
September 30, 2024
Tickers
CCC
From Benzinga
Cannabis Investors 'Actively Chasing' Companies Expanding Beyond The Industry Says Expert
September 27, 2024
Tickers
CCC
From Benzinga
Has Medical Marijuana Been Forgotten In Cannabis Reform? 'Its Therapeutic Benefits Are Critical'
September 27, 2024
Tickers
CCC
From Benzinga
'Medical Marijuana is Still Critical': Balancing Act Between Recreational, Medicinal Markets
September 26, 2024
Tickers
CCC
From Benzinga
California's Hemp Restrictions Could 'Stifle Broader Access' To Therapeutic Products, Expert Warns
September 26, 2024
Tickers
CCC
From Benzinga
Nasdaq-Listed Vaping Company Ispire Reports 31% YoY Increase In 2024 Revenue
September 26, 2024
From Benzinga
LeafLink's New Payment Option Is Vital For Cannabis Retailers Facing Financial Strain
September 26, 2024
From Benzinga
'Investors Are Looking Beyond The Hype': What's Driving Cannabis Investments Today?
September 25, 2024
Tickers
CCC
From Benzinga
Multi-Billion-Dollar Fund Manager Ross Gerber Will Discuss Cannabis And Its Financial Future At This Key Chicago Event
September 25, 2024
From Benzinga
Rescheduling Cannabis: What The First Pro-Legalization Presidential Ticket Could Mean For The Industry
September 25, 2024
Tickers
CCC
From Benzinga
Non-Hallucinogenic Psychedelic Treatment For Anxiety And Depression In Pre-Clinical Models: Enveric Biosciences' Breakthrough Research
September 25, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.